23 Hrs
Source:
وكالة الأنباء العمانية
Merck and Moderna's cancer vaccine shows promise
Merck and Moderna announced preliminary positive results from the third phase of a clinical trial for a personalized mRNA-based vaccine to treat melanoma skin cancer. The results indicate potential effectiveness in improving recovery rates and reducing disease spread, while additional assessments are ongoing to ensure safety and final efficacy. The data has not yet disclosed specific percentages or exact figures.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)